RNA's coming of age as a drug target

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 65, Issue 1, 2009, Pages 171-188

  Vicens, Quentin ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Aminoglycoside; Antibiotic; Recognition; Ribosome; Riboswitch; RNA

Indexed keywords

EID: 76349090175     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-009-9609-7     Document Type: Article

References (211)

1. Frith, M. C., Pheasant, M., Mattick, J. S.: The amazing complexity of the human transcriptome. Eur. J. Hum. Genet. 13, 894-897 (2005).
2. Sharp, P. A.: The centrality of RNA. Cell 136, 577-580 (2009).
3. Williamson, J. R.: Biophysical studies of bacterial ribosome assembly. Curr. Opin. Struct. Biol. 18, 299-304 (2008).
4. Moore, P. B.: The ribosome returned. J. Biol. 8, 8 (2009).
5. Ambros, V.: The functions of animal microRNAs. Nature 431, 350-355 (2004).
6. Meister, G., Tuschl, T.: Mechanisms of gene silencing by double-stranded RNA. Nature 431, 343-349 (2004).
7. Storz, G.: An expanding universe of noncoding RNAs. Science 296, 1260-1263 (2002).
8. Kapranov, P., et al.: RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 316, 1484-1488 (2007).
9. Kim, S. H., et al.: Three-dimensional tertiary structure of yeast phenylalanine transfer RNA. Science 185, 435-440 (1974).
10. Ladner, J. E., et al.: Structure of yeast phenylalanine transfer RNA at 2. 5 Å resolution. Proc. Natl. Acad. Sci. USA. 72, 4414-4418 (1975).
11. Moras, D., et al.: Crystal structure of yeast tRNAAsp. Nature 288, 669-674 (1980).
12. Karp, G.: Gene expression: From transcription to translation. In: Cell and Molecular Biology. Concepts and Experiments, 5th edn, pp. 429-484, Wiley, New York (2008).
13. Cech, T. R., Zaug, A. J., Grabowski, P. J.: In vitro splicing of the ribosomal RNA precursor of Tetrahymena: Involvement of a guanosine nucleotide in the excision of the intervening sequence. Cell 27, 487-496 (1981).
14. Zaug, A. J., Kent, J. R., Cech, T. R.: A labile phosphodiester bond at the ligation junction in a circular intervening sequence RNA. Science 224, 574-578 (1984).
15. Cech, T. R., Herschlag, D., Piccirilli, J. A., Pyle, A. M.: RNA catalysis by a group I ribozyme. Developing a model for transition state stabilization. J. Biol. Chem. 267, 17479-17482 (1992).
16. Piccirilli, J. A., Vyle, J. S., Caruthers, M. H., Cech, T. R.: Metal ion catalysis in the Tetrahymena ribozyme reaction. Nature 361, 85-88 (1993).
17. Steitz, T. A., Steitz, J. A.: A general two-metal-ion mechanism for catalytic RNA. Proc. Natl. Acad. Sci. USA. 90, 6498-6502 (1993).
18. Finkelstein, T., Weinstein, I. B.: Proflavine binding to transfer ribonucleic acid, synthetic ribonucleic acids, and deoxyribonucleic acid. J. Biol. Chem. 242, 3763-3768 (1967).
19. Weinstein, I. B., Finkelstein, I. H.: Proflavine inhibition of protein synthesis. J. Biol. Chem. 242, 3757-3762 (1967).
20. Cundliffe, E.: On the nature of antibiotic binding sites in ribosomes. Biochimie 69, 863-869 (1987).
21. Moazed, D., Noller, H. F.: Interaction of antibiotics with functional sites in 16S ribosomal RNA. Nature 327, 389-394 (1987).
22. Moazed, D., Noller, H. F.: Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA. Biochimie 69, 879-884 (1987).
23. Miyaguchi, H., Narita, H., Sakamoto, K., Yokoyama, S.: An antibiotic-binding motif of an RNA fragment derived from the A-site related region of Escherichia coli 16S RNA. Nucleic Acids Res. 24, 3700-3706 (1996).
24. Purohit, P., Stern, S.: Interactions of a small RNA with antibiotics and RNA ligands of the 30S subunit. Nature 370, 659-662 (1994).
25. Recht, M. I., Fourmy, D., Blanchard, S. C., Dahlquist, K. D., Puglisi, J. D.: RNA sequence determinants for aminoglycoside binding to an A-site rRNA model oligonucleotide. J. Mol. Biol. 262, 421-436 (1996).
26. Fourmy, D., Recht, M. I., Blanchard, S. C., Puglisi, J. D.: Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic. Science 274, 1367-1371 (1996).
27. Yoshizawa, S., Fourmy, D., Puglisi, J. D.: Structural origins of gentamicin antibiotic action. EMBO J. 17, 6437-6448 (1998).
28. Carter, A. P., et al.: Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature 407, 340-348 (2000).
29. Brodersen, D. E., et al.: The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell 103, 1143-1154 (2000).
30. Hansen, J. L., et al.: The structures of four macrolide antibiotics bound to the large ribosomal subunit. Mol. Cell 10, 117-128 (2002).
31. Hansen, J. L., Moore, P. B., Steitz, T. A.: Structures of five antibiotics bound at the peptidyl transferase center of the large ribosomal subunit. J. Mol. Biol. 330, 1061-1075 (2003).
32. Pioletti, M., et al.: Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3. EMBO J. 20, 1829-1839 (2001).
33. Schlünzen, F., et al.: Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413, 814-821 (2001).
34. Ogle, J. M., et al.: Recognition of cognate transfer RNA by the 30S ribosomal subunit. Science 292, 897-902 (2001).
35. Pape, T., Wintermeyer, W., Rodnina, M. V.: Conformational switch in the decoding region of 16S rRNA during aminoacyl-tRNA selection on the ribosome. Nat. Struct. Biol. 7, 104-107 (2000).
36. Davies, J., Gorini, L., Davis, B. D.: Misreading of RNA codewords induced by aminoglycoside antibiotics. Mol. Pharmacol. 1, 93-106 (1965).
37. Davies, J., Davis, B. D.: Misreading of ribonucleic acid code words induced by aminoglycoside antibiotics. J. Biol. Chem. 243, 3312-3316 (1968).
38. Gallego, J., Varani, G.: Targeting RNA with small-molecule drugs: therapeutic promise and chemical challenges. Acc. Chem. Res. 34, 836-843 (2001).
39. Vicens, Q., Westhof, E.: Crystal structure of paromomycin docked into the eubacterial ribosomal decoding A site. Structure 9, 647-658 (2001).
40. Vicens, Q., Westhof, E.: Crystal structure of geneticin bound to a bacterial 16S ribosomal RNA A site oligonucleotide. J. Mol. Biol. 326, 1175-1188 (2003).
41. Shandrick, S., et al.: Monitoring molecular recognition of the ribosomal decoding site. Angew. Chem. Int. Ed. 43, 3177-3182 (2004).
42. Francois, B., et al.: Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding. Nucleic Acids Res. 33, 5677 (2005).
43. Borovinskaya, M. A., et al.: Structural basis for aminoglycoside inhibition of bacterial ribosome recycling. Nat. Struct. Mol. Biol. 14, 727-732 (2007).
44. Borovinskaya, M. A., Shoji, S., Holton, J. M., Fredrick, K., Cate, J. H.: A steric block in translation caused by the antibiotic spectinomycin. ACS Chem. Biol. 2, 545-552 (2007).
45. Kaul, M., Pilch, D. S.: Thermodynamics of aminoglycoside-rRNA recognition: The binding of neomycin-class aminoglycosides to the A site of 16S rRNA. Biochemistry 41, 7695-7706 (2002).
46. Kaul, M., Barbieri, C. M., Kerrigan, J. E., Pilch, D. S.: Coupling of drug protonation to the specific binding of aminoglycosides to the A site of 16 S rRNA: Elucidation of the number of drug amino groups involved and their identities. J. Mol. Biol. 326, 1373-1387 (2003).
47. Kaul, M., Barbieri, C. M., Pilch, D. S.: Aminoglycoside-induced reduction in nucleotide mobility at the ribosomal RNA A-site as a potentially key determinant of antibacterial activity. J. Am. Chem. Soc. 128, 1261-1271 (2006).
48. Yang, G., Trylska, J., Tor, Y., McCammon, J. A.: Binding of aminoglycosidic antibiotics to the oligonucleotide A-site model and 30S ribosomal subunit: Poisson-Boltzmann model, thermal denaturation, and fluorescence studies. J. Med. Chem. 49, 5478-5490 (2006).
49. Vaiana, A. C., Westhof, E., Auffinger, P.: A molecular dynamics simulation study of an aminoglycoside/A-site RNA complex: Conformational and hydration patterns. Biochimie 88, 1061-1073 (2006).
50. Vaiana, A. C., Sanbonmatsu, K. Y.: Stochastic gating and drug-ribosome interactions. J. Mol. Biol. 386, 648-661 (2009).
51. Knowles, D. J., Foloppe, N., Matassova, N. B., Murchie, A. I.: The bacterial ribosome, a promising focus for structure-based drug design. Curr. Opin. Pharmacol. 2, 501-506 (2002).
52. Sutcliffe, J. A.: Improving on nature: antibiotics that target the ribosome. Curr. Opin. Microbiol. 8, 534-542 (2005).
53. Davies, J.: Resistance redux. Infectious diseases, antibiotic resistance and the future of mankind. EMBO Rep. 9, S18-S21 (2008).
54. Mattick, J. S.: RNA regulation: A new genetics? Nat. Rev. Genet. 5, 316-323 (2004).
55. Gottesman, S.: The small RNA regulators of Escherichia coli: roles and mechanisms. Annu. Rev. Microbiol. 58, 303-328 (2004).
56. Nahvi, A., et al.: Genetic control by a metabolite binding mRNA. Chem. Biol. 9, 1043-1049 (2002).
57. Winkler, W., Nahvi, A., Breaker, R. R.: Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expression. Nature 419, 952-956 (2002).
58. Roth, A., Breaker, R. R.: The structural and functional diversity of metabolite-binding riboswitches. Annu Rev Biochem. (2009).
59. Winkler, W. C.: Metabolic monitoring by bacterial mRNAs. Arch. Microbiol. 183, 151-159 (2005).
60. Jacob, F., Monod, J.: Genetic regulatory mechanisms in the synthesis of proteins. J. Mol. Biol. 3, 318-356 (1961).
61. Müller, S.: Another face of RNA: Metabolite-induced "riboswitching" for regulation of gene expression. ChemBioChem 4, 817-819 (2003).
62. Blount, K., Breaker, R.: Riboswitches as antibacterial drug targets. Nat. Biotechnol. 24, 1558-1564 (2006).
63. Blouin, S., Mulhbacher, J., Penedo, J., Lafontaine, D.: Riboswitches: Ancient and promising genetic regulators. ChemBioChem 10, 400-416 (2009).
64. Lehn, J.-M.: Design of organic complexing agents. Strategies towards properties. In: Dunitz, J. D., et al. (eds.) Alkali Metal Complexes with Organic Ligands, pp. 1-69. Springer, New York (1973).
65. Lehn, J.-M.: Supramolecular Chemistry. Concepts and Perspectives. VCH, Weinheim (1995).
66. Cate, J. H., et al.: Crystal structure of a group I ribozyme domain: Principles of RNA packing. Science 273, 1678-1684 (1996).
67. Benzing, T., Tjivikua, T., Wolfe, J., Rebek Jr., J.: Recognition and transport of adenine derivatives with synthetic receptors. Science 242, 266-268 (1988).
68. Batey, R., Gilbert, S., Montange, R. K.: Structure of a natural guanine-responsive riboswitch complexed with the metabolite hypoxanthine. Nature 432, 411-415 (2004).
69. Serganov, A., et al.: Structural basis for discriminative regulation of gene expression by adenine- and guanine-sensing mRNAs. Chem. Biol. 11, 1729-1741 (2004).
70. Mandal, M., Breaker, R.: Adenine riboswitches and gene activation by disruption of a transcription terminator. Nat. Struct. Mol. Biol. 11, 29-35 (2004).
71. Gilbert, S., Stoddard, C., Wise, S., Batey, R.: Thermodynamic and kinetic characterization of ligand binding to the purine riboswitch aptamer domain. J. Mol. Biol. 359, 754-768 (2006).
72. Gilbert, S., Mediatore, S., Batey, R.: Modified pyrimidines specifically bind the purine riboswitch. J. Am. Chem. Soc. 128, 14214-14215 (2006).
73. Edwards, A. L., Batey, R.: A structural basis for the recognition of 2′-deoxyguanosine by the purine riboswitch. J. Mol. Biol. 385, 938-948 (2009).
74. Jenison, R. D., Gill, S. C., Pardi, A., Polisky, B.: High-resolution molecular discrimination by RNA. Science 263, 1425-1429 (1994).
75. Zimmermann, G. R., Jenison, R. D., Wick, C. L., Simorre, J.-P., Pardi, A.: Interlocking structural motifs mediate molecular discrimination by a theophylline-binding RNA. Nat. Struct. Biol. 4, 644-649 (1997).
76. Böttger, E. C., Springer, B., Prammananan, T., Kidan, Y., Sander, P.: Structural basis for selectivity and toxicity of ribosomal antibiotics. EMBO Rep. 2, 318-323 (2001).
77. Prammananan, T., et al.: A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae. J. Infect. Dis. 177, 1573-1581 (1998).
78. Taniguchi, H., et al.: Molecular analysis of kanamycin and viomycin resistance in Mycobacterium smegmatis by use of the conjugation system. J. Bacteriol. 179, 4795-4801 (1997).
79. Pfister, P., Hobbie, S., Vicens, Q., Böttger, E. C., Westhof, E.: The molecular basis for A-site mutations conferring aminoglycoside resistance: Relationship between ribosomal susceptibility and X-ray crystal structures. Chembiochem 4, 1078-1088 (2003).
80. Chaires, J. B.: Energetics of drug-DNA interactions. Biopolymers 44, 201-215 (1997).
81. Serganov, A., Huang, L., Patel, D.: Structural insights into amino acid binding and gene control by a lysine riboswitch. Nature 455, 1263-1267 (2008).
82. Schuwirth, B. S., et al.: Structures of the bacterial ribosome at 3. 5 Å resolution. Science 310, 827-834 (2005).
83. Garst, A., Heroux, A., Rambo, R., Batey, R.: Crystal structure of the lysine riboswitch regulatory mRNA element. J. Biol. Chem. 283, 22347-22351 (2008).
84. Vicens, Q., Westhof, E.: Crystal structure of a complex between the aminoglycoside tobramycin and an oligonucleotide containing the ribosomal decoding A-site. Chem. Biol. 9, 747-755 (2002).
85. Pilch, D. S., Kaul, M., Barbieri, C. M., Kerrigan, J. E.: Thermodynamics of aminoglycoside-rRNA recognition. Biopolymers 70, 58-79 (2003).
86. Kawaguchi, H., Naito, T., Nakagawa, S., Fujisawa, K. I.: BB-K8, a new semisynthetic aminoglycoside antibiotic. J. Antibiot. 25, 695-708 (1972).
87. Kondo, J., François, B., Russell, R. J., Murray, J. B., Westhof, E.: Crystal structure of the bacterial ribosomal decoding site complexed with amikacin containing the gamma-amino-alpha-hydroxybutyryl (haba) group. Biochimie 88, 1027-1031 (2006).
88. Quiocho, F. A., Vyas, N. K.: Novel stereospecificity of the l-arabinose-binding protein. Nature 310, 381-386 (1984).
89. Quiocho, F. A., Wilson, D. K., Vyas, N. K.: Substrate specificity and affinity of a protein modulated by bound water molecules. Nature 340, 404-407 (1989).
90. Ladbury, J. E.: Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug design. Chem. Biol. 3, 973-980 (1996).
91. Watson, J. D., Crick, F. H.: Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature 421, 397-398 (2003).
92. Wilkins, M. H., Strokes, A. R., Wilson, H. R.: Molecular structure of deoxypentose nucleic acids. Nature 421, 398-400 (2003).
93. Wing, R., et al.: Crystal structure analysis of a complete turn of B-DNA. Nature 287, 755-758 (1980).
94. Drew, H. R., et al.: Structure of a B-DNA dodecamer: Conformation and dynamics. Proc. Natl. Acad. Sci. USA. 78, 2179-2183 (1981).
95. Rich, A., Davies, D. R.: A new 2 stranded helical structure - Polyadenylic acid and polyuridylic acid. J. Am. Chem. Soc. 78, 3548-3549 (1956).
96. Day, R. O., Seeman, N. C., Rosenberg, J. M., Rich, A.: Crystalline fragment of double helix - Structure of dinucleoside phosphate guanylyl-3′, 5′-cytidine. Proc. Natl. Acad. Sci. USA. 70, 849-853 (1973).
97. Rosenberg, J. M., et al.: Double helix at atomic resolution. Nature 243, 150-154 (1973).
98. Reddy, B. S., Seshadri, T. P., Sakore, T. D., Sobell, H. M.: Visualization of drug-nucleic acid interactions at atomic resolution. V. Structure of two aminoacridine-dinucleoside monophosphate crystalline complexes, proflavine-5-iodocytidylyl (3′-5′) guanosine and acridine orange-5-iodocytidylyl (3′-5′) guanosine. J. Mol. Biol. 135, 787-812 (1979).
99. Berman, H. M., et al.: Molecular and crystal-structure of an intercalation complex - Proflavine-cytidylyl-(3′, 5′)-guanosine. Biopolymers 18, 2405-2429 (1979).
100. Westhof, E., Rao, S. T., Sundaralingam, M.: Crystallographic studies of drug-nucleic acid interactions: Proflavine intercalation between the non-complementary base-pairs of cytidilyl-3′, 5′-adenosine. J. Mol. Biol. 142, 331-361 (1980).
101. Been, M. D., Perrotta, A. T.: Group I intron self-splicing with adenosine: Evidence for a single nucleoside-binding site. Science 252, 434-437 (1991).
102. Michel, F., Hanna, M., Green, R., Bartel, D. P., Szostak, J. W.: The guanosine binding site of the Tetrahymena ribozyme. Nature 342, 391-395 (1989).
103. Adams, P. L., Stahley, M. R., Kosek, A. B., Wang, J., Strobel, S. A.: Crystal structure of a self-splicing group I intron with both exons. Nature 430, 45-50 (2004).
104. Guo, F., Gooding, A. R., Cech, T. R.: Structure of the Tetrahymena ribozyme: Base triple sandwich and metal ion at the active site. Mol Cell 16, 351-362 (2004).
105. Golden, B. L., Kim, H., Chase, E.: Crystal structure of a phage Twort group I ribozyme-product complex. Nat. Struct. Mol. Biol. 12, 82-89 (2005).
106. Vicens, Q., Cech, T. R.: Atomic level architecture of group I introns revealed. Trends Biochem. Sci. 31, 41-51 (2006).
107. Edwards, T. E., Ferré-D'Amaré, A. R.: Crystal structures of the thi-box riboswitch bound to thiamine pyrophosphate analogs reveal adaptive RNA-small molecule recognition. Structure 14, 1459-1468 (2006).
108. Serganov, A., Huang, L., Patel, D. J.: Coenzyme recognition and gene regulation by a flavin mononucleotide riboswitch. Nature 458, 233-237 (2009).
109. Serganov, A., Polonskaia, A., Phan, A. T., Breaker, R., Patel, D.: Structural basis for gene regulation by a thiamine pyrophosphate-sensing riboswitch. Nature 441, 1167-1171 (2006).
110. Thore, S., Leibundgut, M., Ban, N.: Structure of the eukaryotic thiamine pyrophosphate riboswitch with its regulatory ligand. Science 312, 1208-1211 (2006).
111. Gilbert, S., Love, C. E., Edwards, A. L., Batey, R.: Mutational analysis of the purine riboswitch aptamer domain. Biochemistry 46, 13297-13309 (2007).
112. Mandal, M., Boese, B., Barrick, J., Winkler, W., Breaker, R.: Riboswitches control fundamental biochemical pathways in Bacillus subtilis and other bacteria. Cell 113, 577-586 (2003).
113. Roth, A., et al.: A riboswitch selective for the queuosine precursor preQ1 contains an unusually small aptamer domain. Nat. Struct. Mol. Biol. 14, 308-317 (2007).
114. Kang, M., Peterson, R., Feigon, J.: Structural insights into riboswitch control of the biosynthesis of queuosine, a modified nucleotide found in the anticodon of tRNA. Mol. Cell 33, 784-790 (2009).
115. Klein, D. J., Edwards, T. E., Ferré-D'Amaré, A. R.: Cocrystal structure of a class I preQ1 riboswitch reveals a pseudoknot recognizing an essential hypermodified nucleobase. Nat. Struct. Mol. Biol. 16, 343-344 (2009).
116. Spitale, R. C., Torelli, A. T., Krucinska, J., Bandarian, V., Wedekind, J. E.: The structural basis for recognition of the PreQ0 metabolite by an unusually small riboswitch aptamer domain. J. Biol. Chem. 284, 11012-11016 (2009).
117. Takagi, T., et al.: Computational studies on Ch Pi-interactions. J. Chem. Soc. Perkin Trans. II, 1015-1018 (1987).
118. Brandl, M., Weiss, M. S., Jabs, A., Suhnel, J., Hilgenfeld, R.: C-H pi-interactions in proteins. J. Mol. Biol. 307, 357-377 (2001).
119. Klein, D. J., Wilkinson, S. R., Been, M. D., Ferre-D'Amare, A. R.: Requirement of helix P2. 2 and nucleotide G1 for positioning the cleavage site and cofactor of the glmS ribozyme. J. Mol. Biol. 373, 178-189 (2007).
120. Klein, D. J., Ferre-D'Amare, A. R.: Structural basis of glmS ribozyme activation by glucosamine-6-phosphate. Science 313, 1752-1756 (2006).
121. Cochrane, J. C., Lipchock, S. V., Strobel, S. A.: Structural investigation of the GlmS ribozyme bound to its catalytic cofactor. Chem. Biol. 14, 97-105 (2007).
122. Duan, X., Quiocho, F. A.: Structural evidence for a dominant role of nonpolar interactions in the binding of a transport/chemosensory receptor to its highly polar ligands. Biochemistry 41, 706-712 (2002).
123. Montange, R. K., Batey, R.: Structure of the S-adenosylmethionine riboswitch regulatory mRNA element. Nature 441, 1172-1175 (2006).
124. Dougherty, D. A., Stauffer, D. A.: Acetylcholine binding by a synthetic receptor: Implications for biological recognition. Science 250, 1558-1560 (1990).
125. Harel, M., et al.: Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc. Natl. Acad. Sci. USA. 90, 9031-9035 (1993).
126. Zhong, W., et al.: From ab initio quantum mechanics to molecular neurobiology: A cation-pi binding site in the nicotinic receptor. Proc. Natl. Acad. Sci. USA. 95, 12088-12093 (1998).
127. Brejc, K., et al.: Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411, 269-276 (2001).
128. Gilbert, S., Rambo, R., van Tyne, D., Batey, R.: Structure of the SAM-II riboswitch bound to S-adenosylmethionine. Nat. Struct. Mol. Biol. 15, 177-182 (2008).
129. Lu, C., et al.: Crystal structures of the SAM-III/SMK riboswitch reveal the SAM-dependent translation inhibition mechanism. Nat. Struct. Mol. Biol. 15, 1076-1083 (2008).
130. Griffith, S. C., et al.: Crystal structure of a protein repair methyltransferase from Pyrococcus furiosus with its l-isoaspartyl peptide substrate. J. Mol. Biol. 313, 1103-1116 (2001).
131. Thomas, C. B., Scavetta, R. D., Gumport, R. I., Churchill, M. E.: Structures of liganded and unliganded RsrI N6-adenine DNA methyltransferase: A distinct orientation for active cofactor binding. J. Biol. Chem. 278, 26094-26101 (2003).
132. Schubert, H. L., Blumenthal, R. M., Cheng, X.: Many paths to methyltransfer: A chronicle of convergence. Trends Biochem. Sci. 28, 329-335 (2003).
133. Cate, J. H., Hanna, R. L., Doudna, J. A.: A magnesium ion core at the heart of a ribozyme domain. Nat. Struct. Biol 4, 553-558 (1997).
134. Hermann, T., Westhof, E.: Docking of cationic antibiotics to negatively charged pockets in RNA folds. J. Med. Chem. 42, 1250-1261 (1999).
135. Hermann, T., Westhof, E.: Aminoglycoside binding to the hammerhead ribozyme: A general model for the interaction of cationic antibiotics with RNA. J. Mol. Biol. 276, 903-912 (1998).
136. Wang, H., Tor, Y.: Electrostatic interactions in RNA aminoglycosides binding. J. Am. Chem. Soc. 119, 8734-8735 (1997).
137. Walter, F., Pütz, J., Giegé, R., Westhof, E.: Binding of tobramycin leads to conformational changes in yeast tRNAAsp and inhibition of aminoacylation. EMBO J. 21, 760-768 (2002).
138. Hoch, I., Berens, C., Westhof, E., Schroeder, R.: Antibiotic inhibition of RNA catalysis: neomycin B binds to the catalytic core of the td group I intron displacing essential metal ions. J. Mol. Biol. 282, 557-569 (1998).
139. Zhang, Y., Li, Z., Pilch, D. S., Leibowitz, M. J.: Pentamidine inhibits catalytic activity of group I intron Ca. LSU by altering RNA folding. Nucleic Acids Res. 30, 2961-2971 (2002).
140. Winkler, W., Nahvi, A., Sudarsan, N., Barrick, J., Breaker, R.: An mRNA structure that controls gene expression by binding S-adenosylmethionine. Nat. Struct. Biol. 10, 701-707 (2003).
141. Woodson, S. A.: Metal ions and RNA folding: A highly charged topic with a dynamic future. Curr. Opin. Chem. Biol. 9, 104-109 (2005).
142. Fedor, M. J.: The role of metal ions in RNA catalysis. Curr. Opin. Struct. Biol. 12, 289-295 (2002).
143. Stahley, M. R., Strobel, S. A.: Structural evidence for a two-metal-ion mechanism of group I intron splicing. Science, 309(5740), 1587-1590 (2005).
144. Weinstein, L. B., Jones, B. C., Cosstick, R., Cech, T. R.: A second catalytic metal ion in group I ribozyme. Nature 388, 805-808 (1997).
145. Narlikar, G. J., Gopalakrishnan, V., Mcconnell, T. S., Usman, N., Herschlag, D.: Use of binding-energy by an RNA enzyme for catalysis by positioning and substrate destabilization. Proc. Natl. Acad. Sci. USA. 92, 3668-3672 (1995).
146. Dieckmann, T., Suzuki, E., Nakamura, G., Feigon, J.: Solution structure of an ATP-binding RNA aptamer reveals a novel fold. RNA 2, 628-640 (1996).
147. Carothers, J. M., Davis, J. H., Chou, J. J., Szostak, J. W.: Solution structure of an informationally complex high-affinity RNA aptamer to GTP. RNA 12, 567-579 (2006).
148. Vetter, I. R., Wittinghofer, A.: The guanine nucleotide-binding switch in three dimensions. Science 294, 1299-1304 (2001).
149. Hyun Ryu, D., Rando, R. R.: Aminoglycoside binding to human and bacterial A-site rRNA decoding region constructs. Bioorg. Med. Chem. 9, 2601-2608 (2001).
150. Wong, C.-H., Hendrix, M., Priestley, E. S., Greenberg, W. A.: Specificity of aminoglycoside antibiotics for the A site of the decoding region of ribosomal RNA. Chem. Biol. 5, 397-406 (1998).
151. Botto, R. E., Coxon, B.: Nitrogen-15 nuclear magnetic resonance spectroscopy of neomycin B and related aminoglycosides. J. Am. Chem. Soc. 105, 1021-1028 (1983).
152. Haddad, J., et al.: Design of novel antibiotics that bind to the ribosomal acyltransfer site. J. Am. Chem. Soc. 124, 3229-3237 (2002).
153. Russell, R. J., Murray, J. B., Lentzen, G., Haddad, J., Mobashery, S.: The complex of a designer antibiotic with a model aminoacyl site of the 30S ribosomal subunit revealed by X-ray crystallography. J. Am. Chem. Soc. 125, 3410-3411 (2003).
154. Francois, B., et al.: Antibacterial aminoglycosides with a modified mode of binding to the ribosomal-RNA decoding site. Angew. Chem. Int. Ed. 43, 6735-6738 (2004).
155. Hanessian, S., et al.: Structure-based design, synthesis, and A-site rRNA cocrystal complexes of functionally novel aminoglycoside antibiotics: C2 "ether analogues of paromomycin". J. Med. Chem. 50, 2352-2369 (2007).
156. Kondo, J., et al.: Crystal structure of the bacterial ribosomal decoding site complexed with a synthetic doubly functionalized paromomycin derivative: A new specific binding mode to an A-Minor motif enhances in vitro antibacterial activity. ChemMedChem 2, 1631-1638 (2007).
157. Foloppe, N., et al.: A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site. Bioorg. Med. Chem. 12, 935-947 (2004).
158. Auffinger, P., Hays, F. A., Westhof, E., Ho, P. S.: Halogen bonds in biological molecules. Proc. Natl. Acad. Sci. USA. 101, 16789-16794 (2004).
159. Lu, Y., et al.: Halogen bonding-A novel interaction for rational drug design? J. Med. Chem. 52, 2854-2862 (2009).
160. Auffinger, P., Bielecki, L., Westhof, E.: Anion binding to nucleic acids. Structure 12, 379-388 (2004).
161. Kim, J. N., Breaker, R. R.: Purine sensing by riboswitches. Biol. Cell 100, 1-11 (2008).
162. Wickiser, J. K., Cheah, M. T., Breaker, R. R., Crothers, D. M.: The kinetics of ligand binding by an adenine-sensing riboswitch. Biochemistry 44, 13404-13414 (2005).
163. Jucker, F. M., Phillips, R. M., McCallum, S. A., Pardi, A.: Role of a heterogeneous free state in the formation of a specific RNA-theophylline complex. Biochemistry 42, 2560-2567 (2003).
164. Kondo, J., Westhof, E.: The bacterial and mitochondrial ribosomal A-site molecular switches possess different conformational substates. Nucleic Acids Res. 36, 2654-2666 (2008).
165. Ogle, J. M., Murphy, F. V., Tarry, M. J., Ramakrishnan, V.: Selection of tRNA by the ribosome requires a transition from an open to a closed form. Cell 111, 721-732 (2002).
166. Wimberly, B. T., et al.: Structure of the 30S ribosomal subunit. Nature 407, 327-339 (2000).
167. Williamson, J. R.: Induced fit in RNA-protein recognition. Nat. Struct. Biol. 7, 834-837 (2000).
168. Kaul, M., Barbieri, C. M., Pilch, D. S.: Fluorescence-based approach for detecting and characterizing antibiotic-induced conformational changes in ribosomal RNA: Comparing aminoglycoside binding to prokaryotic and eukaryotic ribosomal RNA sequences. J. Am. Chem. Soc. 126, 3447-3453 (2004).
169. Kondo, J., Urzhumtsev, A., Westhof, E.: Two conformational states in the crystal structure of the Homo sapiens cytoplasmic ribosomal decoding A site. Nucleic acids Res. 34, 676-685 (2006).
170. Detering, C., Varani, G.: Validation of automated docking programs for docking and database screening against RNA drug targets. J. Med. Chem. 47, 4188-4201 (2004).
171. Moitessier, N., Westhof, E., Hanessian, S.: Docking of aminoglycosides to hydrated and flexible RNA. J. Med. Chem. 49, 1023-1033 (2006).
172. Lang, P. T., Brozell, S. R., Mukherjee, S., Pettersen, E. F., Meng, E. C., Thomas, V., Rizzo, R. C., Case, D. A., James, T. L., Kuntz, I. D.: DOCK 6: Combining techniques to model RNA-small molecule complexes. RNA. 15(6), 1219-1230 (2009).
173. Carlson, H. A.: Protein flexibility and drug design: how to hit a moving target. Curr. Opin. Chem. Biol. 6, 447-452 (2002).
174. Meagher, K. L., Carlson, H. A.: Incorporating protein flexibility in structure-based drug discovery: Using HIV-1 protease as a test case. J. Am. Chem. Soc. 126, 13276-13281 (2004).
175. Noeske, J., et al.: Interplay of 'induced fit' and preorganization in the ligand induced folding of the aptamer domain of the guanine binding riboswitch. Nucleic Acids Res. 35, 572-583 (2006).
176. Stoddard, C., Gilbert, S., Batey, R.: Ligand-dependent folding of the three-way junction in the purine riboswitch. RNA 14, 675-684 (2008).
177. Buck, J., Fürtig, B., Noeske, J., Wöhnert, J., Schwalbe, H.: Time-resolved NMR methods resolving ligand-induced RNA folding at atomic resolution. Proc. Natl. Acad. Sci. USA. 104, 15699 (2007).
178. Montange, R. K., Batey, R.: Riboswitches: Emerging themes in RNA structure and function. Annu. Rev. Biophys. 37, 117-133 (2008).
179. Noeske, J., Richter, C., Stirnal, E., Schwalbe, H., Wöhnert, J.: Phosphate-group recognition by the aptamer domain of the thiamine pyrophosphate sensing riboswitch. ChemBioChem 7, 1451-1456 (2006).
180. Grundy, F. J., Lehman, S. C., Henkin, T. M.: The L box regulon: Lysine sensing by leader RNAs of bacterial lysine biosynthesis genes. Proc. Natl. Acad. Sci. USA. 100, 12057-12062 (2003).
181. Rodionov, D. A., Vitreschak, A. G., Mironov, A. A., Gelfand, M. S.: Regulation of lysine biosynthesis and transport genes in bacteria: Yet another RNA riboswitch? Nucleic Acids Res. 31, 6748-6757 (2003).
182. Sudarsan, N., Wickiser, J. K., Nakamura, S., Ebert, M. S., Breaker, R. R.: An mRNA structure in bacteria that controls gene expression by binding lysine. Genes Dev. 17, 2688-2697 (2003).
183. Fox, K. A., et al.: Multiple posttranscriptional regulatory mechanisms partner to control ethanolamine utilization in Enterococcus faecalis. Proc. Natl. Acad. Sci. USA. 106, 4435-4440 (2009).
184. Rodnina, M. V., Wintermeyer, W.: Ribosome fidelity: tRNA discrimination, proofreading and induced fit. Trends Biochem. Sci. 26, 124-130 (2001).
185. Vicens, Q., Westhof, E.: RNA as a drug target: The case of aminoglycosides. ChemBioChem 4, 1018-1023 (2003).
186. Wickiser, J. K., Winkler, W., Breaker, R., Crothers, D. M.: The speed of RNA transcription and metabolite binding kinetics operate an FMN riboswitch. Mol. Cell 18, 49-60 (2005).
187. Sudarsan, N., Cohen-Chalamish, S., Nakamura, S., Emilsson, G. M., Breaker, R.: Thiamine pyrophosphate riboswitches are targets for the antimicrobial compound pyrithiamine. Chem. Biol. 12, 1325-1335 (2005).
188. Lee, E. R., Blount, K. F., Breaker, R. R.: Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression. RNA Biol. 6 (2009).
189. Winkler, W., Cohen-Chalamish, S., Breaker, R.: An mRNA structure that controls gene expression by binding FMN. Proc. Natl. Acad. Sci. USA. 99, 15908-15913 (2002).
190. Cheng, A. C., Calabro, V., Frankel, A. D.: Design of RNA-binding proteins and ligands. Curr. Opin. Struct. Biol. 11, 478-484 (2001).
191. Ataide, S. F., et al.: Mechanisms of resistance to an amino acid antibiotic that targets translation. ACS Chem. Biol. 2, 819-827 (2007).
192. Lu, Y., Chen, N. Y., Paulus, H.: Identification of aecA mutations in Bacillus subtilis as nucleotide substitutions in the untranslated leader region of the aspartokinase II operon. J. Gen. Microbiol. 137, 1135-1143 (1991).
193. Patte, J. C., Akrim, M., Mejean, V.: The leader sequence of the Escherichia coli lysC gene is involved in the regulation of LysC synthesis. FEMS Microbiol. Lett. 169, 165-170 (1998).
194. Christner, P., Yankowski, R. L., Benditt, M., Jimenez, S. A.: Alteration in the conformational stability of collagen caused by the incorporation of the lysine analogue S-2-aminoethylcysteine. Biochim. Biophys. Acta 1294, 37-47 (1996).
195. Jester, B. C., Levengood, J. D., Roy, H., Ibba, M., Devine, K. M.: Nonorthologous replacement of lysyl-tRNA synthetase prevents addition of lysine analogues to the genetic code. Proc. Natl. Acad. Sci. USA. 100, 14351-14356 (2003).
196. von Ahsen, U., Davies, J., Schroeder, R.: Antibiotic inhibition of group I ribozyme function. Nature 353, 368-370 (1991).
197. Waldsich, C., Semrad, K., Schroeder, R.: Neomycin B inhibits splicing of the td intron indirectly by interfering with translation and enhances missplicing in vivo. RNA 4, 1653-1663 (1998).
198. Vourloumis, D., et al.: Aminoglycoside-hybrid ligands targeting the ribosomal decoding site. ChemBioChem 6, 58-65 (2005).
199. Hermann, T.: Chemical and functional diversity of small molecule ligands for RNA. Biopolymers 70, 4-18 (2003).
200. Skripkin, E., et al.: R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance. Antimicrob. Agents Chemother. 52, 3550-3557 (2008).
201. Zhou, J., et al.: Design at the atomic level: generation of novel hybrid biaryloxazolidinones as promising new antibiotics. Bioorg. Med. Chem. Lett. 18, 6179-6183 (2008).
202. Mei, H.-Y., et al.: Inhibition of an HIV-1 Tat-derived peptide binding to TAR RNA by aminoglycoside antibiotics. Bioorg. Med. Chem. Lett. 5, 2755-2760 (1995).
203. Wang, S., Huber, P. W., Cui, M., Czarnik, A. W., Mei, H. Y.: Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism. Biochemistry 37, 5549-5557 (1998).
204. Zapp, M. L., Stern, S., Green, M. R.: Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production. Cell 74, 969-978 (1993).
205. Ennifar, E., et al.: HIV-1 RNA dimerization initiation site is structurally similar to the ribosomal A site and binds aminoglycoside antibiotics. J. Biol. Chem. 278, 2723-2730 (2003).
206. Ennifar, E., et al.: A structure-based approach for targeting the HIV-1 genomic RNA dimerization initiation site. Biochimie 89, 1195-1203 (2007).
207. Costa, F. F.: Non-coding RNAs and new opportunities for the private sector. Drug Discov Today 14, 446-452 (2009).
208. Nudelman, I., et al.: Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations. J. Med. Chem. 52, 2836-2845 (2009).
209. Zhou, J., et al.: Design at the atomic level: design of biaryloxazolidinones as potent orally active antibiotics. Bioorg. Med. Chem. Lett. 18, 6175-6178 (2008).
210. Han, Q., et al.: Molecular recognition by glycoside pseudo base pairs and triples in an apramycin-RNA complex. Angew. Chem. Int. Ed. 44, 2694-2700 (2005).
211. Kondo, J., François, B., Urzhumtsev, A., Westhof, E.: Crystal structure of the Homo sapiens cytoplasmic ribosomal decoding site complexed with apramycin. Angew. Chem. Int. Ed. 45, 3310-3314 (2006).